Trastuzumab as adjuvant therapy for early stage breast cancer - horizon scanning review
NHSC
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
NHSC. Trastuzumab as adjuvant therapy for early stage breast cancer - horizon scanning review. Birmingham: National Horizon Scanning Centre (NHSC). 2005
Authors' objectives
This study aims to assess the potential for future impact of Trastuzumab as adjuvant therapy for early stage breast cancer.
Antineoplastic Agents; Breast Neoplasms /drug therapy
Language Published
English
Country of organisation
England
English summary
An English language summary is available.
Address for correspondence
Department of Public Health&Epidemiology, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Tel: +44 121 414 7831; Fax: +44 121 414 2269; Email: c.packer@bham.ac.uk